CANAQUEST MEDICAL CORPORATION News

CanaQuest and Neeka Health Partner to Conduct Clinical Studies With Mentanine

Seeking AlphaApr 25, 2023 21:56

CBD Combined With Essential Fatty Acids Is 40% More Efficient In Epilepsy Seizure Reduction Than Regular CBD, New Study

CANAQUEST MEDICAL CORP (OTCPK:CANQF), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous syst

Benzinga Real-time NewsDec 9, 2022 21:02

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.TORONTO, ON / ACCESSWIRE / December 8

AccesswireDec 9, 2022 00:20

Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

USERS REPORT INCREASED MENTAL CLARITY,BETTER SLEEP, MORE ENERGY, AND LESS BRAIN FOG AND JOINT STIFFNESSTORONTO, ON / ACCESSWIRE / September 8, 2022 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Comp

AccesswireSep 8, 2022 21:05

Westpac Bank sells Australian life insurance business A $900 million to Daiichi of Japan

Westpac Bank of Australia announced on Monday that it had agreed to sell its life insurance business from Australia to Daiichi Life Insurance of Japan for A $900m (US $660 million). Westpac had previously agreed to sell its general insurance and New Zealand life insurance businesses. The latest deal marks the bank's complete exit from the life insurance business. Australian banks are rapidly pulling out of the insurance business. Companies, including Macquarie Group, Suncorp Group and wealth manager AMP, have reduced their exposure to the industry over the past five years. Yes

新浪財經Aug 9, 2021 08:53